Effects of Bacillus subtilis iturin A on HepG2 cells in vitro and vivo

• Published in: AMB Express
• Main Authors: Haobin Zhao, Lu Yan, Ling Guo, Hui Sun, Qingsheng Huang, Dongyan Shao, Chunmei Jiang, Junling Shi
• Format: Article
• Language: English
• Published: SpringerOpen 2021-05-01
• Subjects: Bacillus subtilis; Iturin A; HepG2; Proliferation; Immune microenvironment; Physiological toxicity
• Online Access: https://doi.org/10.1186/s13568-021-01226-4

Abstract Iturin A with cyclic peptide and fatty acid chain isolated from Bacillus subtilis fermentation shows a variety of biological activities. Among them, the anticancer activity attracted much attention. However, the molecular mechanism of its inhibitory effect on hepatocellular carcinoma was still unclear. Thus its effect on hepatocellular carcinoma was tested in this research. It was found that iturin A could enter HepG2 cells immediately and cause reactive oxygen species burst, disrupt cell cycle and induce apoptosis, paraptosis and autophagy in vitro. The iturin A without fatty acid chain showed no antitumor activity. Amphiphilic is critical to the activity of iturin A. The anticancer activity of iturin A to hepatocellular carcinoma was also verified in mice models carrying xenograft tumors constructed by HepG2 cells. At a dosage of 3 mg/kg/day, iturin A significantly inhibited the further increase of the tumor weight by 58.55%, and reduced the expression of Ki67 in tumor. In the tumor treated with iturin A, lymphocyte infiltration was found, and the expressions of TGF-β1and PD-L1 were decreased, which indicated that the tumor immune microenvironment was improved. Besides, iturin A showed no significant harm on the health of mice except slight disturbance of liver function. These results suggested that iturin A had significant antitumor effect in vitro and vivo, and provide a basis for the application of iturin A as anticancer agent.